Thyrocare Technologies Balance Sheet Health
Financial Health criteria checks 5/6
Thyrocare Technologies has a total shareholder equity of ₹4.9B and total debt of ₹470.2M, which brings its debt-to-equity ratio to 9.6%. Its total assets and total liabilities are ₹5.9B and ₹1.1B respectively. Thyrocare Technologies's EBIT is ₹836.1M making its interest coverage ratio 35.3. It has cash and short-term investments of ₹993.4M.
Key information
9.6%
Debt to equity ratio
₹470.20m
Debt
| Interest coverage ratio | 35.3x |
| Cash | ₹993.40m |
| Equity | ₹4.88b |
| Total liabilities | ₹1.05b |
| Total assets | ₹5.93b |
Recent financial health updates
Recent updates
Getting In Cheap On Thyrocare Technologies Limited (NSE:THYROCARE) Might Be Difficult
Feb 29
Revenue Miss: Thyrocare Technologies Limited Fell 10.0% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 04Here's Why Thyrocare Technologies (NSE:THYROCARE) Can Manage Its Debt Responsibly
Dec 08Why Thyrocare Technologies' (NSE:THYROCARE) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 08Thyrocare Technologies (NSE:THYROCARE) Knows How To Allocate Capital Effectively
Mar 23Thyrocare Technologies Limited (NSE:THYROCARE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Mar 02Investors In Thyrocare Technologies Limited (NSE:THYROCARE) Should Consider This, First
Feb 01Investors Who Bought Thyrocare Technologies (NSE:THYROCARE) Shares A Year Ago Are Now Up 81%
Jan 12
The Chairman & MD of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Just Bought A Few More Shares
Dec 24Under The Bonnet, Thyrocare Technologies' (NSE:THYROCARE) Returns Look Impressive
Dec 17Thyrocare Technologies Limited's (NSE:THYROCARE) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Nov 30Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Nov 02Earnings Update: Thyrocare Technologies Limited (NSE:THYROCARE) Just Reported And Analysts Are Boosting Their Estimates
Nov 01How Does Thyrocare Technologies Limited (NSE:THYROCARE) Fare As A Dividend Stock?
Oct 28Insider Buying: The Thyrocare Technologies Limited (NSE:THYROCARE) Chairman Just Bought ₹20m Worth Of Shares
Oct 07The Thyrocare Technologies (NSE:THYROCARE) Share Price Has Gained 51% And Shareholders Are Hoping For More
Sep 29Will Thyrocare Technologies (NSE:THYROCARE) Repeat Its Return Growth Of The Past?
Sep 11Trade Alert: The Chairman Of Thyrocare Technologies Limited (NSE:THYROCARE), Velumani Arokiaswamy, Has Just Spent ₹9.6m Buying A Few More Shares
Aug 22Thyrocare Technologies Limited's (NSE:THYROCARE) Price In Tune With Earnings
Aug 17Analyst Forecasts For Thyrocare Technologies Limited (NSE:THYROCARE) Are Surging Higher
Jul 30Investor Optimism Abounds Thyrocare Technologies Limited (NSE:THYROCARE) But Growth Is Lacking
Jul 28Should Weakness in Thyrocare Technologies Limited's (NSE:THYROCARE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 04Financial Position Analysis
Short Term Liabilities: THYROCARE's short term assets (₹2.1B) exceed its short term liabilities (₹686.3M).
Long Term Liabilities: THYROCARE's short term assets (₹2.1B) exceed its long term liabilities (₹364.2M).
Debt to Equity History and Analysis
Debt Level: THYROCARE has more cash than its total debt.
Reducing Debt: THYROCARE's debt to equity ratio has increased from 2.2% to 9.6% over the past 5 years.
Debt Coverage: THYROCARE's debt is well covered by operating cash flow (301.6%).
Interest Coverage: THYROCARE's interest payments on its debt are well covered by EBIT (35.3x coverage).